生命科学资讯

On genomics, NGS, and doing much more good than bad, with Markus Vossman - pharmaphorum

Is Illumina Inc Gaining or Losing Market Support? - Benzinga

Illumina (NASDAQ:ILMN) Price Target Raised to $130.00 - MarketBeat

Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? - Nasdaq

Whole genome sequencing of hepatitis A virus: adapting Illumina protocols for foodborne investigation - Nature

What Illumina (ILMN)'s MyOme AI Genomics Partnership Means For Shareholders - simplywall.st

Douglas Lane & Associates LLC Acquires 18,914 Shares of Illumina, Inc. $ILMN - MarketBeat

Illumina (ILMN): Evaluating the Stock’s Valuation After Its Strategic AI-Genomics Partnership With MyOme - Yahoo Finance

Biotech company Illumina loses venture building head Casas - - Global Venturing

Applying 3D correlative structured illumination microscopy and X-ray tomography to characterise herpes simplex virus-1 morphogenesis

The Illumina-Myome Partnership That Could Save $200 Billion in U.S. Healthcare - Inside Precision Medicine

“It can’t wait until tomorrow”: How patient advocacy drives change - Illumina

Ancient genomes illuminate the origins and dynamic history of East Asian cattle | Science

How to transfer data from BaseSpace to Illumina Connected Software - Illumina

Illumina, Inc. $ILMN Shares Acquired by Aaron Wealth Advisors LLC - MarketBeat

Illumina Inc (NASDAQ:ILMN) Nasdaq Futures Shape Discovery Market Now - Kalkine Media

I tested iRESTORE’s Illumina Face Mask — one week in, I’m glowing - New York Post

Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN) - MarketBeat

Sicart Associates LLC Has $7.89 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat

Top Exec Sells Illumina Shares in a Surprising Move! - TipRanks